Norbert F Zander

This inventor holds 26 USPTO granted patents and 18 published patent applications, plus 4 CIPO patents and 20 EPO patents. Top assignees: Siemens Healthcare Diagnostics Products Gmbh, Fresenius Kabi Deutschland Gmbh, Dade Behring Marburg Gmbh. Active years: 1997-2023.

USPTO Granted Patents = 26 (Patent Applications = 18)

% Patents Active = 65.4

CIPO Patents = 4 (Patent Applications = 1)

EPO Patents = 20 (Patent Applications = 41)

Average Co-Inventor Count = 2.4

ph-index = 7

Forward Citations = 103(Granted Patents)

Location History:

Meine, DE (2007 - 2014)
Marburg, DE (1997 - 2023)

Company Filing History:

13 out of 106

Siemens Healthcare Diagnostics Products Gmbh

patents

7 out of 228

Fresenius Kabi Deutschland Gmbh

patents

4 out of 149

Dade Behring Marburg Gmbh

patents

4. 1 out of 340

Behringwerke Aktiengesellschaft

patents

5. 1 out of 1

Behringwerke Diagnostics Gmbh

where one patent can have more than one assignee

Years Active: 1997-2023

Loading Chart...

26 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11774461 - Iron chelator-containing prothrombin time reagent (2023-10-03),

2. 11320439 - Binding assay for the diagnosis of a heparin-induced thrombocytopenia (2022-05-03),

3. 11262357 - Activation assay for the diagnosis of a heparin-induced thrombocytopenia (2022-03-01),

4. 10822636 - Method for determining fibrinogen and automatic analyzer (2020-11-03),

5. 9482673 - Method for simultaneously determining multiple coagulation proteases (2016-11-01),

6. 9205424 - Devices for determining the platelet function in a centrifugal analyzer (2015-12-08),

7. 8932826 - Method for simultaneously determining multiple coagulation proteases (2015-01-13),

8. 8906639 - Method of determining factor XIII with the aid of plasma-based reference material (2014-12-09),

9. 8840879 - Conjugates of hydroxyalkyl starch and a protein (2014-09-23),

10. 8741873 - Controls and kit for thrombocyte activity tests (2014-06-03),

11. 8685636 - Heparin-insensitive method for determining direct coagulation factor inhibitors (2014-04-01),

12. 8618266 - Hasylated polypeptides (2013-12-31),

13. 8475765 - Hydroxyalkyl starch derivatives (2013-07-02),

14. 8304205 - Blood coagulation assays (2012-11-06),

15. 8287850 - Conjugates of hydroxyalkyl starch and a protein, prepared by reductive amination (2012-10-16),

Title: Norbert F Zander - Pioneering Inventor from Marburg

Introduction: Norbert F Zander is a distinguished inventor hailing from Marburg, Germany, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Norbert F Zander holds several recent patents in the areas of renewable energy, artificial intelligence, and medical devices, showcasing his versatility and forward-thinking approach to invention.

Career Highlights: With a career spanning over two decades, Norbert F Zander has worked with leading research institutions and tech companies, consistently pushing the boundaries of what is possible in the realm of technological advancements.

Collaborations: Throughout his career, Norbert F Zander has collaborated with top engineers, scientists, and designers, fostering a culture of innovation and excellence in all his projects.

Conclusion: Norbert F Zander's passion for innovation and his relentless drive to create solutions for the future make him a true pioneer in the world of inventions. His work continues to inspire and shape the landscape of technology worldwide.